Notify me when Chen Zhenfeng M files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals, Inc. | Ordinary Share | 11% | $4,150,370 | 2,255,636 | Chen Zhenfeng | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|